POST Online Media Lite Edition


Immunome appoints Purnanand Sarma as president and CEO

Christian Fernsby |
Exton, Pa., USA - Immunome, a biotechnology company, announced that Purnanand Sarma has joined as president and chief executive officer.

Mr. Sarma brings more than 25 years of industry experience with a proven track record in drug development, fund raising, and growing companies.

Prior to joining Immunome, Mr. Sarma was the President and CEO of Taris Biomedical.

Prior to TARIS, he served in several leadership roles at Cephalon Corporation, which was acquired by Teva Pharmaceutical Industries; Nektar Therapeutics; and SmithKline Beecham, now Glaxo SmithKline.

Mr. Sarma earned his PhD in Pharmaceutics from the University of Minnesota and B. Pharm from Andhra University, Visakhapatnam, India.

LATEST 5 MOVES FROM Pennsylvania 

What to read next

Immunomedics 72 Hour Deadline Alert: Approximately 72 Hours Remain; Former Louisiana Attorney Genera
IMMUNOMEDICS SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of L
ImmunoMet Therapeutics appoints two directors